Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Turnstone Biologics Corp. - Common Stock (NQ: TSBX )

3.180 -0.070 (-2.15%)
Streaming Delayed Price Updated: 1:00 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,082
Open 3.141
Bid (Size) 3.150 (4)
Ask (Size) 3.210 (4)
Prev. Close 3.250
Today's Range 3.141 - 3.259
52wk Range 1.625 - 13.20
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Appoints William Waddill to its Board of Directors
From Turnstone Biologics Corp.
Via GlobeNewswire

Performance

YTD
+22.78%
+22.78%
1 Month
+3.25%
+3.25%
3 Month
+40.71%
+40.71%
6 Month
+43.24%
+43.24%
1 Year
-71.09%
-71.09%

More News

Read More
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023
Via InvestorPlace
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Turnstone Biologics to Participate in Upcoming Investor Conferences
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference
From Turnstone Biologics Corp.
Via GlobeNewswire
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting
From Turnstone Biologics Corp.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber
From Turnstone Biologics Corp.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
From Turnstone Biologics Corp.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3
Via Benzinga
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
From Turnstone Biologics Corp.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.